Skip to main content
ISTH 2023 Main banner
Back

    State-of-the-Art Session

    Platelet Disorders, von Willebrand Disease and Thrombotic Microangiopathies

    Advances in VWD: Translational/Bench to Bedside

    SOA 15.2 - Novel Therapeutics for VWD

    Tuesday, June 27, 2023
    08:25 – 08:50 ET
    Room: 517
    Session Available As: Live-Stream and On-Demand

      Speaker(s)

    • Caterina Casari, PhD (she/her/hers)

      Principal Investigator
      Laboratory for Hemostasis, Inflammation and Thrombosis, Unité Mixte de Recherche S1176, Institut National de la Santé et de la Recherche Médicale, Université Paris-Saclay
      PARIS, Ile-de-France, France

    Please view the 2023 RPTH State-of-the-Art Illustrated Capsules here.

    Learning Objectives:

    • Upon completion, participants will be able to recognize and acknowledge the limitations of available treatments for von Willebrand disease
    • Upon completion, participants will be able to list new potential treatment options for von Willebrand disease aiming to increase von Willebrand factor levels by different mechanisms
    • Upon completion, participants will be able to name and explain how treatments developed to increase the procoagulant potential could be useful options for von Willebrand disease